Showing results (131-140 of 180) with videos related to

Sort By:
Pageof 18
Journal of Personalized Medicine|April 23, 2022
Rhythm Control Better Prevents Dementia than Rate Control Strategies in Patients with Atrial Fibrillation-A Nationwide Cohort StudyJiunn-Cherng Lin, Cheng-Hung Li, Yun-Yu Chen, et al.
Annals of Hematology|April 2, 2014
Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myelomaShang-Yi Huang, Chung-Wu Lin, Hsiu-Hsia Lin, et al.
Cancer Research|March 17, 2006
Nucleophosmin mutations in de novo acute myeloid leukemia: the age-dependent incidences and the stability during disease evolutionWen-Chien Chou, Jih-Luh Tang, Liang-In Lin, et al.
Molecular Cancer Research : MCR|May 9, 2022
Phosphoproteomics Reveals the Role of Constitutive KAP1 Phosphorylation by B-cell Receptor Signaling in Chronic Lymphocytic LeukemiaJung-Lin Wu, Hsin-Yi Wu, Shang-Ju Wu, et al.
BMC Cancer|May 3, 2015
Risk factors and clinical outcomes of acute myeloid leukaemia with central nervous system involvement in adultsChieh-Lung Cheng, Chi-Cheng Li, Hsin-An Hou, et al.
Acta Cardiologica Sinica|January 8, 2025
Rhythm Control Better Prevents Stroke than Rate Control in Patients with Concomitant Hypertrophic Cardiomyopathy and Atrial Fibrillation: A Nationwide Population Based Cohort Study with Long-Term Follow-UpShang-Ju Wu, Yun-Yu Chen, Yu-Shan Chien, et al.
The Journal of Clinical Endocrinology and Metabolism|February 25, 2025
SGLT2i and Cardiovascular Events in Patients With Concomitant Atrial Fibrillation and Diabetes: A TriNetX Cohort StudyYu-Yu Hsiao, Yun-Yu Chen, Ming-Jen Kuo, et al.
American Journal of Hematology|January 21, 2018
Long-term effects of crizotinib in ALK-positive tumors (excluding NSCLC): A phase 1b open-label studyCarlo Gambacorti-Passerini, Sergey Orlov, Li Zhang, et al.
British Journal of Haematology|March 29, 2019
Adoptive donor immunity protects against resolved hepatitis B virus reactivation after allogeneic haematopoietic stem cell transplantation in the world's largest retrospective cohort studyJia-Hau Liu, Xiu-Wen Liao, Chien-Hung Chen, et al.
The New England Journal of Medicine|December 12, 2022
Glofitamab for Relapsed or Refractory Diffuse Large B-Cell LymphomaMichael J Dickinson, Carmelo Carlo-Stella, Franck Morschhauser, et al.
Pageof 18